MPT0B214
MPT0B214 is a microtubule inhibitor that strongly binds to the colchicine binding site of tubulin, preventing tubulin polymerization. MPT0B214 induces apoptosis through a mitochondrial/caspase 9 dependent pathway and shows cytotoxicity across various human tumor cell lines. MPT0B214 can be used for cancer research[1].
Product Specifications
CAS Number
1215208-65-3
UNSPSC
12352005
Target
Apoptosis; Caspase; Microtubule/Tubulin; Mitochondrial Metabolism
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Cytoskeleton; Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/mpt0b214.html
Smiles
O=C(C1=CC(OC)=C(C(OC)=C1)OC)C2=NC3=CC=C(C(N)=C3C=C2)OC
Molecular Formula
C20H20N2O5
Molecular Weight
368.38
References & Citations
[1]Chiang NJ, et al. A novel synthetic microtubule inhibitor, MPT0B214 exhibits antitumor activity in human tumor cells through mitochondria-dependent intrinsic pathway. PLoS One. 2013;8 (3) :e58953.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K1951406 1.0 µg DNA
RPL26P28 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)
Sign In for Pricing
View Details 
GYA06334-01 250 mg
2-Amino-N-methoxy-N-methylacetamide hydrochloride
Sign In for Pricing
View Details GYA06334-02 2.5 g
2-Amino-N-methoxy-N-methylacetamide hydrochloride
Sign In for Pricing
View Details 